U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07427576) titled 'Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte' on Jan. 30.
Brief Summary: House dust mites are the main source of allergies in indoor environments. They are predominant in coastal areas, with the Canary Islands being the autonomous community with the highest percentage of patients with rhinoconjunctivitis due to sensitisation to these mites (94.7%).
Immunotherapy is indicated for the treatment of allergic rhinoconjunctivitis and is capable of altering the natural course of allergic diseases.
The aim of the study was to evaluate the efficacy and safety of Clustoid(R) Max Forte ...